Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-19T05:54:37.157Z Has data issue: false hasContentIssue false

Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery? – CORRIGENDUM

Published online by Cambridge University Press:  24 October 2013

Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Copyright
Copyright © Cambridge University Press 2013 

doi:10.1017/S1047951111000758. First published online by Cambridge University Press 24 May 2011.

The authors would like to apologise for errors within Table 5 and Figure 1 of the above article.1

Table 5 Diagnostic properties of RoTEM® parameters and conventional coagulation tests in children undergoing congenital heart surgery are indicated.

aPTT = activated partial thromboplastin time; AUC = area under the curve for receiver-operating characteristic curve analysis; NPV = negative predictive value; PPV = positive predictive value

True diagnosis is considered a blood loss above 20 ml/kg/24 hours

Figure 1 Scatter plot of post-operative Fib-TEM® maximum clot firmness and fibrinogen in 60 children after surgery for congenital heart disease.

In Table 5, in the “Routine parameters” section of the table, some of the “variables” were positioned on the wrong lines and thus lined up with the wrong row of figures. The corrected table is given below.

In Figure 1, the x-axis was incorrectly labelled. The corrected figure is given below.

These errors have no influence on the interpretation of results or the conclusion of the paper.

References

1. Andreasen, JB, Hvas, A-M, Christiansen, K, Ravn, HB. Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery? Cardiol Young 2011; 21: 684691.CrossRefGoogle ScholarPubMed
Figure 0

Table 5 Diagnostic properties of RoTEM® parameters and conventional coagulation tests in children undergoing congenital heart surgery are indicated.

Figure 1

Figure 1 Scatter plot of post-operative Fib-TEM® maximum clot firmness and fibrinogen in 60 children after surgery for congenital heart disease.